A newly published study in Molecular Cell highlights an exciting advance in topoisomerase biology and potential cancer therapeutics. Importantly, this work was enabled using topoisomerase reagents and assay technologies supplied by TopoGEN. Konada and colleagues report that Heat Shock Factor 1 (HSF1) selectively stimulates the catalytic activity of DNA topoisomerase IIβ (TOP2β) while exerting minimal effects on […]